High-performance liquid chromatographic determination of urinary 4′-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans
- 9 June 1995
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 668 (1) , 125-131
- https://doi.org/10.1016/0378-4347(95)00065-q
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The role of S‐mephenytoin 4'‐hydroxylase in imipramine metabolism by human liver microsomes: a two‐enzyme kinetic analysis of N‐ demethylation and 2‐hydroxylation.British Journal of Clinical Pharmacology, 1994
- Evidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in HumansBiochemistry, 1994
- Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokineticsClinical Pharmacology & Therapeutics, 1992
- S-mephenytoin 4-hydroxylation in older AmericansEuropean Journal of Clinical Pharmacology, 1991
- Genetic polymorphism of S-mephenytoin hydroxylationPharmacology & Therapeutics, 1989
- Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland ChineseClinical Pharmacology & Therapeutics, 1989
- Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatographyAnalytical Biochemistry, 1985
- Mephenytoin hydroxylation polymorphism: Characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivoClinical Pharmacology & Therapeutics, 1985
- Genetic polymorphism of mephenytoin p(4′)‐hydroxylation: difference between Orientals and Caucasians.British Journal of Clinical Pharmacology, 1985
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984